|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02252 MEDBOT-B
Nominal 
27.340 0.000 (0.000%) Ranking Overview
Ranking based on 2 research report(s)
Average Ranking 2.50
|
Strong Buy (1)
0
|
Buy (2)
1
|
Hold (3)
1
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2025 | EPS | -24.00 RMB (cts) | |
| Net Profit | -249.66 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2026 | 87.00 | 8.50 | 0 | -- | 261.00 | -87.00 |
| 2027 | 412.50 | 40.50 | 0 | -- | 701.00 | 124.00 |
| 2028 | 829.50 | 81.50 | 0 | -- | 1,260.00 | 399.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2026 | 261.00 | 26.00 | -- | JP MORGAN | Overweight | 42.00 | 08/04/2026 | |
| 2026 | -87.00 | -9.00 | -- | UBS | Neutral | 21.40 | 01/04/2026 | |
| 2027 | 701.00 | 69.00 | -- | JP MORGAN | -- | -- | 08/04/2026 | |
| 2027 | 124.00 | 12.00 | -- | UBS | -- | -- | 01/04/2026 | |
| 2028 | 1,260.00 | 123.00 | -- | JP MORGAN | -- | -- | 08/04/2026 | |
| 2028 | 399.00 | 40.00 | -- | UBS | -- | -- | 01/04/2026 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 09/04/2026 18:00 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -249,660 |
| %Change | -61.137% |
| EPS / (LPS) | RMB -0.240 |
| NBV Per Share (¥) | RMB 0.398 |